ghk-cu copper peptide cancer risk evidence Frontiers 5 GHK Cu Peptide Injection
Description
One 144-hour interval instead of one 168-hour interval simply does not create a pharmacologically significant dip or spike
Studie 6: Zchrana pi ligaci cvy Citace: Vukojevic J., Siroglavic M., Kasnik K., et al
All patients underwent CTP on admission and follow-up non-contrast CT 24 hours post-EVT
This limitation is shared by most unmodified peptides and is why pharmaceutical peptide drugs require extensive chemical modification or alternative delivery routes
